Eiger Biopharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Revenue	15.77	13.48	12.14	0	0	0	0	0	0	0	Upgrade
Revenue Growth (YoY)	16.98%	11.05%	-	-	-	-	-	-	-	-	Upgrade
Cost of Revenue	0.02	1.84	0.75	0	0	0	0	0	0	0	Upgrade
Gross Profit	15.75	11.65	11.4	0	0	0	0	0	0	0	Upgrade
Selling, General & Admin	25.2	29.11	23.9	20.56	17.11	13.96	12	13.11	4.86	0.87	Upgrade
Research & Development	62.33	75.28	64.44	41.59	51.79	37.09	29.52	33.01	8.12	0.64	Upgrade
Operating Expenses	87.54	104.39	88.34	62.15	68.9	51.05	41.52	46.12	12.97	1.52	Upgrade
Operating Income	-71.79	-92.74	-76.94	-62.15	-68.9	-51.05	-41.52	-46.12	-12.97	-1.52	Upgrade
Interest Expense / Income	5.47	4.13	3.56	3.59	3.41	2.33	1.52	0.69	0.35	0	Upgrade
Other Expense / Income	-2.3	-0.12	-46.65	-0.69	-2.06	-0.99	-0.6	0.28	-	-	Upgrade
Pretax Income	-74.96	-96.75	-33.85	-65.05	-70.25	-52.39	-42.45	-47.09	-13.32	-1.52	Upgrade
Income Tax	0.01	0.02	0.06	0	0	0	0	0	0	0	Upgrade
Net Income	-74.96	-96.78	-33.92	-65.05	-70.25	-52.39	-42.45	-47.09	-13.32	-1.52	Upgrade
Shares Outstanding (Basic)	1	1	1	1	1	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	1	1	1	1	0	0	0	0	0	Upgrade
Shares Change	6.39%	22.64%	20.61%	23.51%	67.12%	56.21%	45.30%	2704.01%	10.51%	228.85%	Upgrade
EPS (Basic)	-50.78	-69.74	-30.00	-69.30	-92.40	-115.20	-145.80	-235.20	-1865.70	-234.60	Upgrade
EPS (Diluted)	-50.78	-69.74	-30.00	-69.30	-92.40	-115.20	-145.80	-235.20	-1865.70	-234.60	Upgrade
Free Cash Flow	-74.78	-83.35	-71.29	-63.44	-64.09	-42.81	-38.42	-38.03	-9.18	-1.28	Upgrade
Free Cash Flow Per Share	-50.66	-60.07	-63.00	-67.63	-84.38	-94.20	-132.04	-189.92	-1285.41	-198.56	Upgrade
Gross Margin	99.85%	86.38%	93.86%	-	-	-	-	-	-	-	Upgrade
Operating Margin	-455.12%	-687.78%	-633.66%	-	-	-	-	-	-	-	Upgrade
Profit Margin	-475.26%	-717.71%	-279.34%	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-474.11%	-618.14%	-587.10%	-	-	-	-	-	-	-	Upgrade
EBITDA	-68.74	-91.78	-29.5	-60.81	-66.36	-50.01	-40.88	-46.37	-12.96	-1.51	Upgrade
EBITDA Margin	-435.81%	-680.65%	-242.92%	-	-	-	-	-	-	-	Upgrade
Depreciation & Amortization	0.75	0.84	0.8	0.65	0.49	0.05	0.04	0.02	0.01	0.01	Upgrade
EBIT	-69.49	-92.62	-30.29	-61.46	-66.85	-50.06	-40.92	-46.4	-12.97	-1.52	Upgrade
EBIT Margin	-440.57%	-686.90%	-249.50%	-	-	-	-	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).